Heredodegenerative Disorders, Nervous System

Subtype terms (26)

More specific conditions that are subtypes of Heredodegenerative Disorders, Nervous System in the MeSH hierarchy.

• Alexander Disease

  1 drug experimental

• Amyloid Neuropathies, Familial

  10 drugs (7 approved, 3 experimental)

• Bulbo-Spinal Atrophy, X-Linked

  8 drugs (4 approved, 4 experimental)

• Canavan Disease

  7 drugs (3 approved, 4 experimental)

• Cockayne Syndrome

  1 drug approved

• Dystonia Musculorum Deformans
• Gerstmann-Straussler-Scheinker Disease
• Hepatolenticular Degeneration

  23 drugs (11 approved, 12 experimental)

• Hereditary Central Nervous System Demyelinating Diseases
• Hereditary Sensory and Autonomic Neuropathies

  3 drugs (2 approved, 1 experimental)

• Hereditary Sensory and Motor Neuropathy

  4 drugs (2 approved, 2 experimental)

• Huntington Disease

  97 drugs (44 approved, 53 experimental)

• Lafora Disease

  2 drugs experimental

• Myotonia Congenita

  4 drugs approved

• Myotonic Dystrophy

  18 drugs (8 approved, 10 experimental)

• Neuroacanthocytosis
• Neurofibromatoses

  21 drugs (17 approved, 4 experimental)

• Neuronal Ceroid-Lipofuscinoses

  18 drugs (6 approved, 12 experimental)

• Optic Atrophies, Hereditary

  1 drug experimental

• Pantothenate Kinase-Associated Neurodegeneration

  2 drugs (1 approved, 1 experimental)

• Spinal Muscular Atrophies of Childhood

  14 drugs (9 approved, 5 experimental)

• Spinocerebellar Degenerations

  5 drugs (2 approved, 3 experimental)

• Tourette Syndrome

  49 drugs (31 approved, 18 experimental)

• Tuberous Sclerosis

  16 drugs (11 approved, 5 experimental)

• Unverricht-Lundborg Syndrome

  3 drugs approved

• X-Linked Intellectual Disability

  1 drug approved

Drugs by status

Organizations